Related Experiment Video
Updated: Jul 4, 2026
05:23
Investigating Migraine-Like Behavior Using Light Aversion in Mice
Published on: August 11, 2021
Common pathophysiologic mechanisms in migraine and epilepsy.
1Department of Neurology, University of California Davis School of Medicine, 4860 Y St, Ste 3700, Sacramento, CA 95817, USA. rogawski@ucdavis.edu
Archives of Neurology
|June 11, 2008
Summary
Migraine and epilepsy share common triggers and genetic links. Understanding these shared mechanisms, like cortical spreading depression, can lead to better treatments for both episodic disorders.
Area of Science:
- Neurology
- Neuroscience
- Epileptology
Background:
- Migraine and epilepsy are episodic neurological disorders with overlapping pathophysiologies.
- Both conditions can be triggered by excessive neocortical cellular excitability.
- Genetic mutations affecting ion channels (channelopathies) are implicated in some forms of both migraine and epilepsy.
Purpose of the Study:
- To explore the shared pathophysiologic mechanisms between migraine and epilepsy.
- To highlight the role of NMDA receptors in cortical spreading depression and its relevance to migraine.
- To provide a basis for developing improved therapeutic strategies for both conditions.
Main Methods:
- Comparative analysis of pathophysiologic mechanisms in migraine and epilepsy.
- Review of genetic studies identifying common gene mutations.
- Examination of the role of ionotropic glutamate receptors, particularly NMDA receptors.
Main Results:
- Migraine and epilepsy share common triggers and genetic underpinnings.
- Cortical spreading depression in migraine and hypersynchronous activity in epilepsy stem from similar excitability issues.
- Antiepileptic drugs like valproate, topiramate, and gabapentin show efficacy in treating migraine.
Conclusions:
- Shared cellular and molecular mechanisms exist between migraine and epilepsy.
- Understanding these commonalities, especially concerning NMDA receptors and cortical spreading depression, is crucial.
- This knowledge can guide the development of novel treatments effective for both migraine and epilepsy.
Related Concept Videos
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:29Increased Intracranial Pressure ll: Pathophysiology
Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:22Cerebral Edema ll: Pathophysiology
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
01:20Seizures l: Introduction
Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...